Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice.

Hagemeyer N, Boretius S, Ott C, Von Streitberg A, Welpinghus H, Sperling S, Frahm J, Simons M, Ghezzi P, Ehrenreich H.

Mol Med. 2012 May 9;18:628-35. doi: 10.2119/molmed.2011.00457.

2.

The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination.

Slowik A, Schmidt T, Beyer C, Amor S, Clarner T, Kipp M.

Br J Pharmacol. 2015 Jan;172(1):80-92. doi: 10.1111/bph.12938. Epub 2014 Dec 15.

3.

Regional differences between grey and white matter in cuprizone induced demyelination.

Gudi V, Moharregh-Khiabani D, Skripuletz T, Koutsoudaki PN, Kotsiari A, Skuljec J, Trebst C, Stangel M.

Brain Res. 2009 Aug 4;1283:127-38. doi: 10.1016/j.brainres.2009.06.005. Epub 2009 Jun 12.

PMID:
19524552
4.

Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum.

Guglielmetti C, Praet J, Rangarajan JR, Vreys R, De Vocht N, Maes F, Verhoye M, Ponsaerts P, Van der Linden A.

Neuroimage. 2014 Feb 1;86:99-110. doi: 10.1016/j.neuroimage.2013.07.080. Epub 2013 Aug 7.

5.

Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Steelman AJ, Thompson JP, Li J.

Neurosci Res. 2012 Jan;72(1):32-42. doi: 10.1016/j.neures.2011.10.002. Epub 2011 Oct 12.

6.

The cuprizone model: regional heterogeneity of pathology.

Wergeland S, Torkildsen Ø, Myhr KM, Mørk SJ, Bø L.

APMIS. 2012 Aug;120(8):648-57. doi: 10.1111/j.1600-0463.2012.02882.x. Epub 2012 Feb 24.

PMID:
22779688
7.

Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice.

Irvine KA, Blakemore WF.

J Neuroimmunol. 2006 Jun;175(1-2):69-76. Epub 2006 Apr 19.

PMID:
16626812
8.

The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis.

Kipp M, Norkus A, Krauspe B, Clarner T, Berger K, van der Valk P, Amor S, Beyer C.

Inflamm Res. 2011 Aug;60(8):723-6. doi: 10.1007/s00011-011-0339-0. Epub 2011 Apr 24.

9.

Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features.

Xie M, Tobin JE, Budde MD, Chen CI, Trinkaus K, Cross AH, McDaniel DP, Song SK, Armstrong RC.

J Neuropathol Exp Neurol. 2010 Jul;69(7):704-16. doi: 10.1097/NEN.0b013e3181e3de90.

10.

Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.

Hiremath MM, Saito Y, Knapp GW, Ting JP, Suzuki K, Matsushima GK.

J Neuroimmunol. 1998 Dec 1;92(1-2):38-49.

PMID:
9916878
11.

Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage.

Yoshikawa K, Palumbo S, Toscano CD, Bosetti F.

Prostaglandins Leukot Essent Fatty Acids. 2011 Jul;85(1):43-52. doi: 10.1016/j.plefa.2011.04.022. Epub 2011 May 8.

12.

Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination.

Thiessen JD, Zhang Y, Zhang H, Wang L, Buist R, Del Bigio MR, Kong J, Li XM, Martin M.

NMR Biomed. 2013 Nov;26(11):1562-81. doi: 10.1002/nbm.2992. Epub 2013 Aug 13.

PMID:
23943390
13.

Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle.

Taylor LC, Gilmore W, Ting JP, Matsushima GK.

J Neurosci Res. 2010 Feb 1;88(2):391-402. doi: 10.1002/jnr.22215.

PMID:
19746424
14.

Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.

Tanaka T, Murakami K, Bando Y, Yoshida S.

J Neurochem. 2013 Oct;127(2):259-70. doi: 10.1111/jnc.12289. Epub 2013 May 20.

15.

Beneficial effects of minocycline on cuprizone induced cortical demyelination.

Skripuletz T, Miller E, Moharregh-Khiabani D, Blank A, Pul R, Gudi V, Trebst C, Stangel M.

Neurochem Res. 2010 Sep;35(9):1422-33. doi: 10.1007/s11064-010-0202-7. Epub 2010 Jun 11.

PMID:
20544279
16.

Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.

Goldberg J, Clarner T, Beyer C, Kipp M.

J Mol Neurosci. 2015 Oct;57(2):166-75. doi: 10.1007/s12031-015-0595-5. Epub 2015 Jun 12.

PMID:
26067430
17.

Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.

Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, Linsmeier F, Trebst C, Stangel M.

Am J Pathol. 2008 Apr;172(4):1053-61. doi: 10.2353/ajpath.2008.070850. Epub 2008 Mar 18.

18.

Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination.

Falangola MF, Guilfoyle DN, Tabesh A, Hui ES, Nie X, Jensen JH, Gerum SV, Hu C, LaFrancois J, Collins HR, Helpern JA.

NMR Biomed. 2014 Aug;27(8):948-57. doi: 10.1002/nbm.3140. Epub 2014 Jun 3.

19.

17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice.

Acs P, Kipp M, Norkute A, Johann S, Clarner T, Braun A, Berente Z, Komoly S, Beyer C.

Glia. 2009 Jun;57(8):807-14. doi: 10.1002/glia.20806.

PMID:
19031445
20.

Demyelination increases radial diffusivity in corpus callosum of mouse brain.

Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, Cross AH, Armstrong RC.

Neuroimage. 2005 May 15;26(1):132-40.

PMID:
15862213

Supplemental Content

Support Center